Výsledky vyhledávání - "Whitney Sarchiapone"

Table S2 from Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study

Tissue fusion transcript panel gene coverage (55 genes)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19638daa588e5670ddaf2cec5bd2e0d5
https://doi.org/10.1158/1078-0432.22477848.v1

Zobrazit plný text záznamu

Data from Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study

Purpose:The clinical utility of plasma cell-free DNA (cfDNA) has not been assessed prospectively in patients with glioblastoma (GBM). We aimed to determine the prognostic impact of plasma cfDNA in GBM, as well as its role as a surrogate of tumor burd

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a91c2d19a3301d7ef331635b3e66b0
https://doi.org/10.1158/1078-0432.c.6529773

Zobrazit plný text záznamu

Table S3 from Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study

Circulating tumor DNA next-generation sequencing gene coverage (74 genes)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bca94e0b88a8108e0f34546f89b5642
https://doi.org/10.1158/1078-0432.22477845.v1

Zobrazit plný text záznamu

Table S1 from Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study

Tissue next-generation sequencing gene coverage (152 genes)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19596f4682d646911b24e7dd9bad1221
https://doi.org/10.1158/1078-0432.22477851.v1

Zobrazit plný text záznamu

Figure S1 from Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study

Plasma cell-free DNA (cfDNA) concentration (ng/mL) is correlated with (A), total radiographic tumor burden (contrast-enhancing tumor + T2/FLAIR non-enhancing tumor) and (B), contrast-enhancing tumor burden at the first post-radiation MRI scan in pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ba4638fe7aa521e90713a9067acdfb2
https://doi.org/10.1158/1078-0432.22477854

Zobrazit plný text záznamu

Table S4 from Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study

Complete list of variants detected in 20 subjects who had both tissue and plasma next generation sequencing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed5a999783119210f4d031338e4ce4d
https://doi.org/10.1158/1078-0432.22477842

Zobrazit plný text záznamu

Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study

Publikováno v: Clin Cancer Res

Purpose: The clinical utility of plasma cell-free DNA (cfDNA) has not been assessed prospectively in patients with glioblastoma (GBM). We aimed to determine the prognostic impact of plasma cfDNA in GBM, as well as its role as a surrogate of tumor bur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fe9f3e1182feafaa1fc07b21a626163
https://pubmed.ncbi.nlm.nih.gov/32358025

Zobrazit plný text záznamu

Arterial Spin Labeling and Dynamic Susceptibility Contrast-enhanced MR Imaging for evaluation of arteriovenous shunting and tumor hypoxia in glioblastoma

Autor: Samantha Guiry, Donald M. O'Rourke, Hamed Akbari, S. Ali Nabavizadeh, Steven Brem, Jeffrey B. Ware, Timothy Prior, Christos Davatzikos, Whitney Sarchiapone, Scott Levy, Ronald L. Wolf, Arati Desai, John A. Detre, MacLean Nasrallah, Stephen J Bagley

Publikováno v: Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults and carries a dismal prognosis. Significant challenges in the care of patients with GBM include marked vascular heterogeneity and arteriovenous (AV) shunting, which results

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75d3354ad1f70d6e29af71fa186fcd13
http://europepmc.org/articles/PMC6584644

Zobrazit plný text záznamu

PATH-49. CLINICAL UTILITY OF PLASMA CELL-FREE DNA IN ADULT PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA – A PILOT PROSPECTIVE STUDY

Autor: Stephen J Bagley, Scott Levy, Seyed Ali Nabavizadeh, Arati Desai, Jazmine Mays, Jeffrey B. Ware, Timothy Prior, MacLean Nasrallah, Whitney Sarchiapone, Zev A. Binder, Samantha Guiry, Jacob Till, Stephanie S. Yee, Steven Brem, Jasmin Hussain, Erica L. Carpenter, Andrew Cucciara, Donald M. O'Rourke

Publikováno v: Neuro Oncol

BACKGROUND Liquid biopsy has been not been widely utilized in patients with glioblastoma (GBM) compared to other solid tumors. However, the clinical utility of plasma cell-free DNA (cfDNA) in GBM has not been assessed prospectively or at the time of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51d4b5018fa75cfcc2a0b3c05d4f32fa
https://doi.org/10.1093/neuonc/noz175.645

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání